Mobile Site ›

Clopidogrel Platelet Function Tests

Caveats and Controversies


Receive notification when new Hot Topics are published:

Why Do Genetic Testing?

Slide 28

December 2011

Patients with two loss of function alleles are at risk of experiencing thrombosis while taking clopidogrel. Increasing the dose for these patients may not be adequate and they may require a change of medication. The number of poor metabolizers is approximately 4% of European Americans and African Americans and is somewhat higher in Asian Americans. People from Polynesia or Micronesia have a much higher likelihood of being poor metabolizers.

Why Do Genetic Testing?


Jump to section: